ABCL icon

AbCellera Biologics
ABCL

Overview Fund Activity

127 hedge funds and large institutions have $279M invested in AbCellera Biologics in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 49 reducing their positions, and 28 closing their positions.

Holders
127
Holders Change
-19
Holders Change %
-13.01%
% of All Funds
1.73%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
32
Reduced
49
Closed
28
Calls
$682K
Puts
$927K
Net Calls
-$245K
Net Calls Change
+$82K

Top Buyers

1
UBS AM
1
UBS AM
Illinois
$34.9M
2
Capital World Investors
2
Capital World Investors
California
$29.8M
3
UBS Group
3
UBS Group
Switzerland
$11.3M
4
Citadel Advisors
4
Citadel Advisors
Florida
$4.05M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$6.45M

Top Sellers

1
PM
1
Prosight Management
Texas
$6.28M
2
Norges Bank
2
Norges Bank
Norway
$0
3
OM
3
Opaleye Management
Massachusetts
$0
4
Baillie Gifford & Co
4
Baillie Gifford & Co
United Kingdom
$25M
5
Millennium Management
5
Millennium Management
New York
$1.94M
Name Market Value Shares Shares
Change 		Shares
Change %
PWA
151
Physician Wealth Advisors
Utah
– – -593 Closed
RS
152
R Squared
Hong Kong
– – -470 Closed
CFO
153
CVA Family Office
Colorado
– – -339 Closed
MBFW
154
Morton Brown Family Wealth
Pennsylvania
– – -75 Closed
CFG
155
CKW Financial Group
Hawaii
– – -50 Closed
CFGS
156
Concourse Financial Group Securities
Alabama
– – – –
3 4 5 6
7